These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1782810)

  • 1. Phosphorylated neurofilament epitopes in the achromasic neurons of corticonigral degeneration.
    Wang LN; Kowall NW; Richardson EP
    Chin Med J (Engl); 1991 Dec; 104(12):1011-7. PubMed ID: 1782810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical and ultrastructural studies of Pick's disease.
    Murayama S; Mori H; Ihara Y; Tomonaga M
    Ann Neurol; 1990 Apr; 27(4):394-405. PubMed ID: 2162145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes.
    Dickson DW; Yen SH; Suzuki KI; Davies P; Garcia JH; Hirano A
    Acta Neuropathol; 1986; 71(3-4):216-23. PubMed ID: 2432750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin.
    Lowe J; Errington DR; Lennox G; Pike I; Spendlove I; Landon M; Mayer RJ
    Neuropathol Appl Neurobiol; 1992 Aug; 18(4):341-50. PubMed ID: 1528389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panencephalopathic type of Creutzfeldt-Jakob disease with neuropathologic features similar to Pick's disease.
    Pietrini V; Danieli D; Bevilacqua P; Lechi A
    Clin Neuropathol; 1993; 12(1):1-6. PubMed ID: 7679958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study.
    Munoz-Garcia D; Ludwin SK
    Ann Neurol; 1984 Oct; 16(4):467-80. PubMed ID: 6093681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topography of Pick body distribution in Pick's disease: a contribution to understanding the relationship between Pick's and Alzheimer's diseases.
    Yoshimura N
    Clin Neuropathol; 1989; 8(1):1-6. PubMed ID: 2539932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filaments of Pick's bodies contain altered cytoskeletal elements.
    Perry G; Stewart D; Friedman R; Manetto V; Autilio-Gambetti L; Gambetti P
    Am J Pathol; 1987 Jun; 127(3):559-68. PubMed ID: 3296772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
    Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
    Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
    Shepherd CE; Thiel E; McCann H; Halliday GM
    Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoskeletal immunohistochemistry of Alzheimer's disease.
    Ulrich J; Anderton BH; Brion JP; Euler M; Probst A
    J Neural Transm Suppl; 1987; 24():197-204. PubMed ID: 3479523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC; King CE; McCormack GH; Vickers JC
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.
    Bussière T; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
    J Comp Neurol; 2003 Aug; 463(3):281-302. PubMed ID: 12820162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sharing of specific antigens by degenerating neurons in Pick's disease and Alzheimer's disease.
    Rasool CG; Selkoe DJ
    N Engl J Med; 1985 Mar; 312(11):700-5. PubMed ID: 2579334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.